Cargando…

Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality worldwide. While cirrhosis is the main risk factor for HCC, the factors influencing progression from cirrhosis to HCC remain largely unknown. Gut microbiota plays a key role in liver diseases; however, its associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lapidot, Yelena, Amir, Amnon, Nosenko, Rita, Uzan-Yulzari, Atara, Veitsman, Ella, Cohen-Ezra, Oranit, Davidov, Yana, Weiss, Peretz, Bradichevski, Tanya, Segev, Shlomo, Koren, Omry, Safran, Michal, Ben-Ari, Ziv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300357/
https://www.ncbi.nlm.nih.gov/pubmed/32546668
http://dx.doi.org/10.1128/mSystems.00153-20
_version_ 1783547571266912256
author Lapidot, Yelena
Amir, Amnon
Nosenko, Rita
Uzan-Yulzari, Atara
Veitsman, Ella
Cohen-Ezra, Oranit
Davidov, Yana
Weiss, Peretz
Bradichevski, Tanya
Segev, Shlomo
Koren, Omry
Safran, Michal
Ben-Ari, Ziv
author_facet Lapidot, Yelena
Amir, Amnon
Nosenko, Rita
Uzan-Yulzari, Atara
Veitsman, Ella
Cohen-Ezra, Oranit
Davidov, Yana
Weiss, Peretz
Bradichevski, Tanya
Segev, Shlomo
Koren, Omry
Safran, Michal
Ben-Ari, Ziv
author_sort Lapidot, Yelena
collection PubMed
description Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality worldwide. While cirrhosis is the main risk factor for HCC, the factors influencing progression from cirrhosis to HCC remain largely unknown. Gut microbiota plays a key role in liver diseases; however, its association with HCC remains elusive. This study aimed to elucidate microbial differences between patients with HCC-associated cirrhosis (HCC-cirrhosis) and cirrhotic patients without HCC and healthy volunteers and to explore the associations between diet, lifestyle, and the microbiome of these patients. Fecal samples and food frequency questionnaires were collected from 95 individuals (30 HCC-cirrhosis patients, 38 cirrhotic patients without HCC, and 27 age- and body mass index [BMI]-matched healthy volunteers). 16S rRNA gene sequencing was performed. Bacterial richness in cirrhosis and HCC-cirrhosis patients was significantly lower than in healthy controls. The HCC-cirrhosis group was successfully classified with an area under the curve (AUC) value of 0.9 based on the dysbiotic fecal microbial signature. The HCC-cirrhosis group had a significant overrepresentation of Clostridium and CF231 and reduced Alphaproteobacteria abundance compared to cirrhotic patients without HCC. Patients with HCC-cirrhosis who were overweight displayed significantly decreased bacterial richness and altered microbiota composition compared to their normal-weight counterparts. There was a significant correlation in the HCC-cirrhosis group between intake of artificial sweeteners and the presence of Akkermansia muciniphila. A unique microbial signature was observed in patients with HCC-cirrhosis, irrespective of cirrhosis stage, diet, or treatment. BMI, dietary sugar, and artificial sweeteners were significantly associated with alterations in the microbiome of HCC-cirrhosis patients. However, the increased abundance of Clostridium and CF231 observed in HCC-cirrhosis patients was not influenced by environmental factors, implying that this change was due to development of HCC. IMPORTANCE Development of hepatocellular carcinoma in patients with cirrhosis is associated with alterations in intestinal microbiota, including an escalation of dysbiosis and reduced bacterial richness. This study demonstrates that reduced bacterial richness and dysbiosis escalate with the progression of cirrhosis from compensated to decompensated cirrhosis and to HCC-associated cirrhosis (HCC-cirrhosis). Moreover, we report for the first time the effect of environmental factors on HCC-cirrhosis. Excess weight was associated with increased dysbiosis in patients with HCC compared to their normal-weight counterparts. Moreover, fatty liver, consumption of artificial sweeteners, and high-sugar foods were associated with altered microbial composition, including altered levels of Akkermansia muciniphila in HCC-cirrhosis. We have successfully determined that levels of Alphaproteobacteria and the two genera CF231 and Clostridium are significantly altered in cirrhotic patients who develop hepatocellular carcinoma, independently of cirrhosis severity and dietary habits.
format Online
Article
Text
id pubmed-7300357
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-73003572020-06-25 Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma Lapidot, Yelena Amir, Amnon Nosenko, Rita Uzan-Yulzari, Atara Veitsman, Ella Cohen-Ezra, Oranit Davidov, Yana Weiss, Peretz Bradichevski, Tanya Segev, Shlomo Koren, Omry Safran, Michal Ben-Ari, Ziv mSystems Research Article Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality worldwide. While cirrhosis is the main risk factor for HCC, the factors influencing progression from cirrhosis to HCC remain largely unknown. Gut microbiota plays a key role in liver diseases; however, its association with HCC remains elusive. This study aimed to elucidate microbial differences between patients with HCC-associated cirrhosis (HCC-cirrhosis) and cirrhotic patients without HCC and healthy volunteers and to explore the associations between diet, lifestyle, and the microbiome of these patients. Fecal samples and food frequency questionnaires were collected from 95 individuals (30 HCC-cirrhosis patients, 38 cirrhotic patients without HCC, and 27 age- and body mass index [BMI]-matched healthy volunteers). 16S rRNA gene sequencing was performed. Bacterial richness in cirrhosis and HCC-cirrhosis patients was significantly lower than in healthy controls. The HCC-cirrhosis group was successfully classified with an area under the curve (AUC) value of 0.9 based on the dysbiotic fecal microbial signature. The HCC-cirrhosis group had a significant overrepresentation of Clostridium and CF231 and reduced Alphaproteobacteria abundance compared to cirrhotic patients without HCC. Patients with HCC-cirrhosis who were overweight displayed significantly decreased bacterial richness and altered microbiota composition compared to their normal-weight counterparts. There was a significant correlation in the HCC-cirrhosis group between intake of artificial sweeteners and the presence of Akkermansia muciniphila. A unique microbial signature was observed in patients with HCC-cirrhosis, irrespective of cirrhosis stage, diet, or treatment. BMI, dietary sugar, and artificial sweeteners were significantly associated with alterations in the microbiome of HCC-cirrhosis patients. However, the increased abundance of Clostridium and CF231 observed in HCC-cirrhosis patients was not influenced by environmental factors, implying that this change was due to development of HCC. IMPORTANCE Development of hepatocellular carcinoma in patients with cirrhosis is associated with alterations in intestinal microbiota, including an escalation of dysbiosis and reduced bacterial richness. This study demonstrates that reduced bacterial richness and dysbiosis escalate with the progression of cirrhosis from compensated to decompensated cirrhosis and to HCC-associated cirrhosis (HCC-cirrhosis). Moreover, we report for the first time the effect of environmental factors on HCC-cirrhosis. Excess weight was associated with increased dysbiosis in patients with HCC compared to their normal-weight counterparts. Moreover, fatty liver, consumption of artificial sweeteners, and high-sugar foods were associated with altered microbial composition, including altered levels of Akkermansia muciniphila in HCC-cirrhosis. We have successfully determined that levels of Alphaproteobacteria and the two genera CF231 and Clostridium are significantly altered in cirrhotic patients who develop hepatocellular carcinoma, independently of cirrhosis severity and dietary habits. American Society for Microbiology 2020-06-16 /pmc/articles/PMC7300357/ /pubmed/32546668 http://dx.doi.org/10.1128/mSystems.00153-20 Text en Copyright © 2020 Lapidot et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Lapidot, Yelena
Amir, Amnon
Nosenko, Rita
Uzan-Yulzari, Atara
Veitsman, Ella
Cohen-Ezra, Oranit
Davidov, Yana
Weiss, Peretz
Bradichevski, Tanya
Segev, Shlomo
Koren, Omry
Safran, Michal
Ben-Ari, Ziv
Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma
title Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma
title_full Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma
title_fullStr Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma
title_full_unstemmed Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma
title_short Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma
title_sort alterations in the gut microbiome in the progression of cirrhosis to hepatocellular carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300357/
https://www.ncbi.nlm.nih.gov/pubmed/32546668
http://dx.doi.org/10.1128/mSystems.00153-20
work_keys_str_mv AT lapidotyelena alterationsinthegutmicrobiomeintheprogressionofcirrhosistohepatocellularcarcinoma
AT amiramnon alterationsinthegutmicrobiomeintheprogressionofcirrhosistohepatocellularcarcinoma
AT nosenkorita alterationsinthegutmicrobiomeintheprogressionofcirrhosistohepatocellularcarcinoma
AT uzanyulzariatara alterationsinthegutmicrobiomeintheprogressionofcirrhosistohepatocellularcarcinoma
AT veitsmanella alterationsinthegutmicrobiomeintheprogressionofcirrhosistohepatocellularcarcinoma
AT cohenezraoranit alterationsinthegutmicrobiomeintheprogressionofcirrhosistohepatocellularcarcinoma
AT davidovyana alterationsinthegutmicrobiomeintheprogressionofcirrhosistohepatocellularcarcinoma
AT weissperetz alterationsinthegutmicrobiomeintheprogressionofcirrhosistohepatocellularcarcinoma
AT bradichevskitanya alterationsinthegutmicrobiomeintheprogressionofcirrhosistohepatocellularcarcinoma
AT segevshlomo alterationsinthegutmicrobiomeintheprogressionofcirrhosistohepatocellularcarcinoma
AT korenomry alterationsinthegutmicrobiomeintheprogressionofcirrhosistohepatocellularcarcinoma
AT safranmichal alterationsinthegutmicrobiomeintheprogressionofcirrhosistohepatocellularcarcinoma
AT benariziv alterationsinthegutmicrobiomeintheprogressionofcirrhosistohepatocellularcarcinoma